Detección de anticuerpos contra el VHC y los factores de riesgo en la población con acceso a la seguridad social en México

Ríos-Castillo, B.; Duque-Molina, C.; Borrayo-Sánchez, G.; Medina-Chávez, J.H.; Pineda-Ruiz, E.; Rosales-Piñón, A.; Niebla-Fuentes, M.R.; Santana-Ramírez, A.M.; Treviño-Pérez, S.C.; Avilés-Hernández, R.; Reyna-Sevilla, A.

doi:10.1016/j.rgmx.2024.01.005

Revista de Gastroenterología de México

2024

DOI: 10.1016/j.rgmx.2024.01.005

|View full text |Cite

Detección de anticuerpos contra el VHC y los factores de riesgo en la población con acceso a la seguridad social en México

B. Ríos-Castillo,

C. Duque-Molina,

G. Borrayo-Sánchez

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Advances in the Elimination of Viral Hepatitis in Mexico: A Local Perspective on the Global Initiative

Santos-López,

Panduro,

Sosa-Jurado

et al. 2024

Pathogens

View full text Add to dashboard Cite

Viral hepatitis (A–E) presents a major global health challenge. In 2015, the World Health Organization (WHO) launched an initiative to eliminate viral hepatitis, with the aim of reducing new infections by 90% and deaths by 65% by 2030. Mexico is one of 38 focus countries identified by the WHO, collectively accounting for 80% of global infections and deaths. While hepatitis B and C are commonly diagnosed in Mexico, routine diagnosis for hepatitis D and E is lacking, with no specific epidemiological data available. In 2020, Mexico implemented the National Hepatitis C Elimination Program, focusing on preventing new infections, reducing complications like cirrhosis and hepatocellular carcinoma, ensuring access to treatment, and improving patient care. However, this program has not been extended to hepatitis B and E. Addressing the challenges of viral hepatitis control in Mexico requires increased resource allocation, expanded diagnosis, vaccination for hepatitis A and B, and treatment coverage for hepatitis B and C, along with multisectoral engagement. This work provides an overview of Mexico’s response to the global initiative, highlighting its progress, challenges, and areas of opportunity.

show abstract

Advances in the Elimination of Viral Hepatitis in Mexico: A Local Perspective on the Global Initiative

Santos-López,

Panduro,

Sosa-Jurado

et al. 2024

Pathogens

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Detección de anticuerpos contra el VHC y los factores de riesgo en la población con acceso a la seguridad social en México

Cited by 1 publication

References 11 publications

Advances in the Elimination of Viral Hepatitis in Mexico: A Local Perspective on the Global Initiative

Advances in the Elimination of Viral Hepatitis in Mexico: A Local Perspective on the Global Initiative

Contact Info

Product

Resources

About